Sartorius, DE0007165631

JPMorgan kept its EUR 295.00 target for Sartorius stock

Published on 10/16/2026 at 10:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sartorius stock costs EUR 262.10 on October 16, 2026, 0.11 percent above the Xetra close. Third-quarter results are due on October 22, 2026.

Analyst view and company growth

  • JPMorgan kept its EUR 295.00 target for Sartorius on October 12, 2026.
  • First-half operational sales rose 7.70 percent, while underlying EBITDA reached EUR 548 million.
  • Sartorius stock trades at EUR 262.10 at 10:04 a.m. CEST at Lang & Schwarz on October 16, 2026, 0.11 percent above the Xetra close of October 15, 2026.
  • The next reporting date is October 22, 2026.
Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

Sartorius stock was trading at EUR 262.10 at Lang & Schwarz on October 16, 2026 at 10:04 a.m. CEST, 0.11 percent above the Xetra close of October 15, 2026 at EUR 261.80. JPMorgan kept its EUR 295.00 target and Overweight rating for Sartorius on October 12, 2026, according to FinanzNachrichten.de.

What supports the EUR 295.00 target?

Sartorius reported first-half 2026 operational sales growth of 7.70 percent in constant currencies. Underlying EBITDA increased 3.90 percent to EUR 548 million, lifting the margin by 50 basis points to 30.30 percent, according to Yahoo Finance. Management confirmed full-year sales growth guidance of 5.00 to 9.00 percent and an underlying EBITDA margin above 30.00 percent.

Three dates frame the stock

On July 23, 2026, Sartorius presented first-half sales growth of 7.70 percent and a 30.30 percent underlying EBITDA margin, as reported by Yahoo Finance. On September 28, 2026, JPMorgan retained its EUR 295.00 target, according to Wallstreet Online. On October 12, 2026, the bank again kept the EUR 295.00 target and Overweight rating, according to FinanzNachrichten.de.

The next reporting date

Sartorius lists its nine-month 2026 results conference call for October 22, 2026 at 1:00 p.m. CEST on its Sartorius investor-relations page. That date gives the market its next test of the confirmed guidance range.

Stock stays below its yearly high

The EUR 262.10 quote is below Sartorius' 52-week high of EUR 271.90 and sits within a market capitalization of EUR 18.0 billion as of October 16, 2026. The current price was trading at EUR 262.10 at Lang & Schwarz on October 16, 2026 at 10:04 a.m. CEST, 0.11 percent above the Xetra close of October 15, 2026 at EUR 261.80.

The further course of trading is shown by the continuously updated real-time quote of Sartorius stock.

Sartorius stock facts

  • Company: Sartorius AG
  • ISIN: DE0007165631
  • WKN: 716563
  • Ticker: SRT3
  • Primary exchange: Xetra
  • Price Lang & Schwarz (as of October 16, 2026, 10:04 a.m. CEST): EUR 262.10
  • Change versus Xetra close: plus 0.11 percent
  • Xetra close (October 15, 2026): EUR 261.80
  • Market capitalization: EUR 18.0 billion (as of October 16, 2026)
  • 52-week range: EUR 198.50-271.90 (as of October 16, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies
  • Index membership: MDAX

Market context: Market report DAX.

More news and analyses on Sartorius stock

Disclaimer...
en | DE0007165631 | SARTORIUS | boerse | 70337922 | bgmi